nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—autonomic nervous system—type 1 diabetes mellitus	0.0553	0.15	CbGeAlD
Loperamide—POMC—peripheral nervous system—type 1 diabetes mellitus	0.0399	0.108	CbGeAlD
Loperamide—POMC—nerve—type 1 diabetes mellitus	0.0311	0.0845	CbGeAlD
Loperamide—CACNA1A—nerve—type 1 diabetes mellitus	0.0297	0.0807	CbGeAlD
Loperamide—CALM1—autonomic nervous system—type 1 diabetes mellitus	0.015	0.0408	CbGeAlD
Loperamide—CACNA1A—islet of Langerhans—type 1 diabetes mellitus	0.0144	0.0391	CbGeAlD
Loperamide—OPRM1—nerve—type 1 diabetes mellitus	0.0117	0.0318	CbGeAlD
Loperamide—CALM2—peripheral nervous system—type 1 diabetes mellitus	0.0109	0.0296	CbGeAlD
Loperamide—POMC—cardiovascular system—type 1 diabetes mellitus	0.0109	0.0296	CbGeAlD
Loperamide—CALM1—peripheral nervous system—type 1 diabetes mellitus	0.0108	0.0295	CbGeAlD
Loperamide—POMC—kidney—type 1 diabetes mellitus	0.0107	0.029	CbGeAlD
Loperamide—POMC—pancreas—type 1 diabetes mellitus	0.0106	0.0288	CbGeAlD
Loperamide—POMC—lymphoid tissue—type 1 diabetes mellitus	0.00915	0.0249	CbGeAlD
Loperamide—CALM2—nerve—type 1 diabetes mellitus	0.00849	0.0231	CbGeAlD
Loperamide—CALM1—nerve—type 1 diabetes mellitus	0.00845	0.023	CbGeAlD
Loperamide—OPRD1—kidney—type 1 diabetes mellitus	0.00588	0.016	CbGeAlD
Loperamide—CALM3—islet of Langerhans—type 1 diabetes mellitus	0.00524	0.0142	CbGeAlD
Loperamide—CALM3—retina—type 1 diabetes mellitus	0.00448	0.0122	CbGeAlD
Loperamide—CALM3—nephron tubule—type 1 diabetes mellitus	0.00422	0.0115	CbGeAlD
Loperamide—CALM2—islet of Langerhans—type 1 diabetes mellitus	0.00411	0.0112	CbGeAlD
Loperamide—CALM1—islet of Langerhans—type 1 diabetes mellitus	0.00409	0.0111	CbGeAlD
Loperamide—CALM3—pancreas—type 1 diabetes mellitus	0.00368	0.01	CbGeAlD
Loperamide—CALM2—retina—type 1 diabetes mellitus	0.00352	0.00956	CbGeAlD
Loperamide—CALM1—retina—type 1 diabetes mellitus	0.0035	0.00951	CbGeAlD
Loperamide—CALM2—nephron tubule—type 1 diabetes mellitus	0.00331	0.009	CbGeAlD
Loperamide—CALM1—nephron tubule—type 1 diabetes mellitus	0.0033	0.00896	CbGeAlD
Loperamide—CALM2—cardiovascular system—type 1 diabetes mellitus	0.00297	0.00808	CbGeAlD
Loperamide—CALM1—cardiovascular system—type 1 diabetes mellitus	0.00296	0.00805	CbGeAlD
Loperamide—CALM2—kidney—type 1 diabetes mellitus	0.00291	0.00791	CbGeAlD
Loperamide—CALM1—kidney—type 1 diabetes mellitus	0.0029	0.00787	CbGeAlD
Loperamide—Mepenzolate—CHRM2—type 1 diabetes mellitus	0.00289	0.364	CrCbGaD
Loperamide—CALM2—pancreas—type 1 diabetes mellitus	0.00289	0.00786	CbGeAlD
Loperamide—CALM1—pancreas—type 1 diabetes mellitus	0.00288	0.00782	CbGeAlD
Loperamide—Diphenidol—CHRM2—type 1 diabetes mellitus	0.00254	0.319	CrCbGaD
Loperamide—Darifenacin—CHRM2—type 1 diabetes mellitus	0.00252	0.317	CrCbGaD
Loperamide—CALM2—lymphoid tissue—type 1 diabetes mellitus	0.0025	0.00679	CbGeAlD
Loperamide—CALM1—lymphoid tissue—type 1 diabetes mellitus	0.00249	0.00676	CbGeAlD
Loperamide—CYP2B6—nephron tubule—type 1 diabetes mellitus	0.00246	0.00669	CbGeAlD
Loperamide—CYP2C8—kidney—type 1 diabetes mellitus	0.00241	0.00656	CbGeAlD
Loperamide—CYP2B6—cardiovascular system—type 1 diabetes mellitus	0.00221	0.00601	CbGeAlD
Loperamide—CYP2B6—kidney—type 1 diabetes mellitus	0.00216	0.00588	CbGeAlD
Loperamide—CYP2B6—lymphoid tissue—type 1 diabetes mellitus	0.00186	0.00505	CbGeAlD
Loperamide—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00163	0.00444	CbGeAlD
Loperamide—CYP3A4—kidney—type 1 diabetes mellitus	0.00163	0.00444	CbGeAlD
Loperamide—CYP2D6—kidney—type 1 diabetes mellitus	0.00161	0.00437	CbGeAlD
Loperamide—ABCB1—retina—type 1 diabetes mellitus	0.0014	0.0038	CbGeAlD
Loperamide—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00132	0.00358	CbGeAlD
Loperamide—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00118	0.00321	CbGeAlD
Loperamide—ABCB1—kidney—type 1 diabetes mellitus	0.00116	0.00314	CbGeAlD
Loperamide—ABCB1—pancreas—type 1 diabetes mellitus	0.00115	0.00312	CbGeAlD
Loperamide—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000993	0.0027	CbGeAlD
Loperamide—CALM2—Immune System—HLA-B—type 1 diabetes mellitus	4.28e-05	6.86e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	4.28e-05	6.85e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—ERBB3—type 1 diabetes mellitus	4.28e-05	6.85e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.27e-05	6.85e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CD86—type 1 diabetes mellitus	4.23e-05	6.79e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CD86—type 1 diabetes mellitus	4.23e-05	6.79e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SST—type 1 diabetes mellitus	4.22e-05	6.76e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD4—type 1 diabetes mellitus	4.21e-05	6.75e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD4—type 1 diabetes mellitus	4.21e-05	6.75e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	4.2e-05	6.73e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—IL6—type 1 diabetes mellitus	4.16e-05	6.66e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—IL6—type 1 diabetes mellitus	4.16e-05	6.66e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL2RA—type 1 diabetes mellitus	4.14e-05	6.64e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—ERBB3—type 1 diabetes mellitus	4.14e-05	6.63e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—ERBB3—type 1 diabetes mellitus	4.14e-05	6.63e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	4.13e-05	6.62e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.11e-05	6.59e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	4.1e-05	6.58e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-A—type 1 diabetes mellitus	4.1e-05	6.57e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SST—type 1 diabetes mellitus	4.08e-05	6.54e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SST—type 1 diabetes mellitus	4.08e-05	6.54e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	4.06e-05	6.51e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	4.06e-05	6.51e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.04e-05	6.47e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	4.04e-05	6.47e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	4.03e-05	6.46e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL2RA—type 1 diabetes mellitus	4.01e-05	6.42e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL2RA—type 1 diabetes mellitus	4.01e-05	6.42e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-A—type 1 diabetes mellitus	3.96e-05	6.35e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-A—type 1 diabetes mellitus	3.96e-05	6.35e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—ERBB3—type 1 diabetes mellitus	3.95e-05	6.33e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	3.91e-05	6.27e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	3.91e-05	6.27e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CRP—type 1 diabetes mellitus	3.91e-05	6.26e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.91e-05	6.26e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.89e-05	6.23e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CCR5—type 1 diabetes mellitus	3.88e-05	6.22e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—ERBB3—type 1 diabetes mellitus	3.82e-05	6.12e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—ERBB3—type 1 diabetes mellitus	3.82e-05	6.12e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CAT—type 1 diabetes mellitus	3.81e-05	6.1e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—HLA-A—type 1 diabetes mellitus	3.78e-05	6.06e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CRP—type 1 diabetes mellitus	3.78e-05	6.06e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CRP—type 1 diabetes mellitus	3.78e-05	6.06e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GCG—type 1 diabetes mellitus	3.76e-05	6.03e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CCR5—type 1 diabetes mellitus	3.76e-05	6.02e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CCR5—type 1 diabetes mellitus	3.76e-05	6.02e-05	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.75e-05	6.01e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-DRB1—type 1 diabetes mellitus	3.74e-05	6e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CAT—type 1 diabetes mellitus	3.68e-05	5.9e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CAT—type 1 diabetes mellitus	3.68e-05	5.9e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—HLA-A—type 1 diabetes mellitus	3.66e-05	5.86e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—HLA-A—type 1 diabetes mellitus	3.66e-05	5.86e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GCG—type 1 diabetes mellitus	3.64e-05	5.83e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GCG—type 1 diabetes mellitus	3.64e-05	5.83e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-DRB1—type 1 diabetes mellitus	3.62e-05	5.8e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-DRB1—type 1 diabetes mellitus	3.62e-05	5.8e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	3.62e-05	5.8e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	3.61e-05	5.79e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.61e-05	5.78e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.54e-05	5.68e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VAV1—type 1 diabetes mellitus	3.52e-05	5.63e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	3.51e-05	5.62e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	3.5e-05	5.61e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	3.5e-05	5.61e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD80—type 1 diabetes mellitus	3.46e-05	5.54e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.43e-05	5.5e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.42e-05	5.49e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	3.41e-05	5.47e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	3.41e-05	5.46e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.41e-05	5.46e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	3.4e-05	5.45e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	3.4e-05	5.45e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	3.4e-05	5.45e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	3.39e-05	5.43e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	3.39e-05	5.43e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD80—type 1 diabetes mellitus	3.35e-05	5.36e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD80—type 1 diabetes mellitus	3.35e-05	5.36e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	3.31e-05	5.31e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.3e-05	5.29e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS2—type 1 diabetes mellitus	3.29e-05	5.27e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.29e-05	5.26e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	3.21e-05	5.15e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.2e-05	5.12e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CD80—type 1 diabetes mellitus	3.19e-05	5.12e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—EGFR—type 1 diabetes mellitus	3.19e-05	5.11e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS2—type 1 diabetes mellitus	3.18e-05	5.1e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS2—type 1 diabetes mellitus	3.18e-05	5.1e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.18e-05	5.1e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.09e-05	4.95e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.09e-05	4.95e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CD80—type 1 diabetes mellitus	3.09e-05	4.95e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CD80—type 1 diabetes mellitus	3.09e-05	4.95e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—EGFR—type 1 diabetes mellitus	3.09e-05	4.95e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—EGFR—type 1 diabetes mellitus	3.09e-05	4.95e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.08e-05	4.93e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.08e-05	4.93e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CD86—type 1 diabetes mellitus	3.07e-05	4.91e-05	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—EGFR—type 1 diabetes mellitus	3.06e-05	4.91e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.05e-05	4.89e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—INS—type 1 diabetes mellitus	3.02e-05	4.84e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.01e-05	4.82e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	3e-05	4.81e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.99e-05	4.8e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.99e-05	4.79e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CD86—type 1 diabetes mellitus	2.97e-05	4.75e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CD86—type 1 diabetes mellitus	2.97e-05	4.75e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—EGFR—type 1 diabetes mellitus	2.96e-05	4.75e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—EGFR—type 1 diabetes mellitus	2.96e-05	4.75e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—TYK2—type 1 diabetes mellitus	2.92e-05	4.68e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—INS—type 1 diabetes mellitus	2.92e-05	4.68e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—INS—type 1 diabetes mellitus	2.92e-05	4.68e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.91e-05	4.66e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	2.89e-05	4.62e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.88e-05	4.62e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	2.87e-05	4.6e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—TYK2—type 1 diabetes mellitus	2.82e-05	4.53e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—TYK2—type 1 diabetes mellitus	2.82e-05	4.53e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.81e-05	4.51e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.81e-05	4.51e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.76e-05	4.43e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IFNG—type 1 diabetes mellitus	2.73e-05	4.38e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	2.72e-05	4.36e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.72e-05	4.36e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	2.7e-05	4.33e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—TYK2—type 1 diabetes mellitus	2.7e-05	4.32e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	2.68e-05	4.3e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.68e-05	4.29e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.67e-05	4.28e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.67e-05	4.28e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.66e-05	4.26e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS3—type 1 diabetes mellitus	2.65e-05	4.24e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IFNG—type 1 diabetes mellitus	2.64e-05	4.24e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IFNG—type 1 diabetes mellitus	2.64e-05	4.24e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD4—type 1 diabetes mellitus	2.64e-05	4.23e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	2.64e-05	4.22e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.63e-05	4.21e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.63e-05	4.21e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.62e-05	4.2e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—TYK2—type 1 diabetes mellitus	2.61e-05	4.18e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—TYK2—type 1 diabetes mellitus	2.61e-05	4.18e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	2.6e-05	4.16e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.59e-05	4.15e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.59e-05	4.15e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.57e-05	4.12e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.57e-05	4.12e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS3—type 1 diabetes mellitus	2.56e-05	4.1e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS3—type 1 diabetes mellitus	2.56e-05	4.1e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD4—type 1 diabetes mellitus	2.55e-05	4.09e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD4—type 1 diabetes mellitus	2.55e-05	4.09e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.54e-05	4.07e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.54e-05	4.07e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—INS—type 1 diabetes mellitus	2.53e-05	4.05e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.53e-05	4.05e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.52e-05	4.05e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—type 1 diabetes mellitus	2.45e-05	3.93e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—INS—type 1 diabetes mellitus	2.44e-05	3.92e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—INS—type 1 diabetes mellitus	2.44e-05	3.92e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—type 1 diabetes mellitus	2.44e-05	3.91e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CD4—type 1 diabetes mellitus	2.44e-05	3.91e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL2—type 1 diabetes mellitus	2.43e-05	3.89e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	2.38e-05	3.81e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—type 1 diabetes mellitus	2.37e-05	3.8e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—type 1 diabetes mellitus	2.37e-05	3.8e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—type 1 diabetes mellitus	2.36e-05	3.78e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—type 1 diabetes mellitus	2.36e-05	3.78e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CD4—type 1 diabetes mellitus	2.36e-05	3.78e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CD4—type 1 diabetes mellitus	2.36e-05	3.78e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL2—type 1 diabetes mellitus	2.35e-05	3.77e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL2—type 1 diabetes mellitus	2.35e-05	3.77e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ALB—type 1 diabetes mellitus	2.32e-05	3.71e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.3e-05	3.68e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	2.28e-05	3.65e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—type 1 diabetes mellitus	2.24e-05	3.59e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—type 1 diabetes mellitus	2.24e-05	3.59e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CD80—type 1 diabetes mellitus	2.24e-05	3.58e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—type 1 diabetes mellitus	2.22e-05	3.55e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	2.2e-05	3.52e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CD80—type 1 diabetes mellitus	2.16e-05	3.47e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CD80—type 1 diabetes mellitus	2.16e-05	3.47e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—type 1 diabetes mellitus	2.14e-05	3.44e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—type 1 diabetes mellitus	2.14e-05	3.44e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.14e-05	3.42e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—INS—type 1 diabetes mellitus	2.11e-05	3.39e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	2.1e-05	3.36e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—STAT3—type 1 diabetes mellitus	2.04e-05	3.28e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—INS—type 1 diabetes mellitus	2.04e-05	3.28e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—INS—type 1 diabetes mellitus	2.04e-05	3.28e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.04e-05	3.27e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.03e-05	3.26e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	2.02e-05	3.23e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.01e-05	3.23e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—STAT3—type 1 diabetes mellitus	1.98e-05	3.17e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—STAT3—type 1 diabetes mellitus	1.98e-05	3.17e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.98e-05	3.17e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.98e-05	3.17e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.97e-05	3.15e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.97e-05	3.15e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.94e-05	3.11e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	1.93e-05	3.09e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—INS—type 1 diabetes mellitus	1.92e-05	3.07e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.89e-05	3.02e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—STAT3—type 1 diabetes mellitus	1.89e-05	3.02e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—EGFR—type 1 diabetes mellitus	1.86e-05	2.98e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.85e-05	2.97e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.83e-05	2.93e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.83e-05	2.93e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—STAT3—type 1 diabetes mellitus	1.83e-05	2.93e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—STAT3—type 1 diabetes mellitus	1.83e-05	2.93e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	1.8e-05	2.89e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—EGFR—type 1 diabetes mellitus	1.8e-05	2.88e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—EGFR—type 1 diabetes mellitus	1.8e-05	2.88e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.79e-05	2.87e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.79e-05	2.87e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	1.78e-05	2.85e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.76e-05	2.83e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	1.76e-05	2.81e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—EGFR—type 1 diabetes mellitus	1.72e-05	2.75e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	1.68e-05	2.69e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—EGFR—type 1 diabetes mellitus	1.66e-05	2.66e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—EGFR—type 1 diabetes mellitus	1.66e-05	2.66e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	1.65e-05	2.65e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	1.58e-05	2.54e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.57e-05	2.52e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2—type 1 diabetes mellitus	1.57e-05	2.52e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.56e-05	2.5e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.52e-05	2.44e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.52e-05	2.44e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2—type 1 diabetes mellitus	1.52e-05	2.43e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.52e-05	2.43e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.51e-05	2.42e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.51e-05	2.42e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.49e-05	2.39e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—type 1 diabetes mellitus	1.43e-05	2.29e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—type 1 diabetes mellitus	1.38e-05	2.21e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—type 1 diabetes mellitus	1.38e-05	2.21e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.32e-05	2.12e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—type 1 diabetes mellitus	1.32e-05	2.11e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.28e-05	2.05e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.28e-05	2.05e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—type 1 diabetes mellitus	1.28e-05	2.04e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—type 1 diabetes mellitus	1.28e-05	2.04e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.2e-05	1.93e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.18e-05	1.89e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.16e-05	1.86e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.16e-05	1.86e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.08e-05	1.73e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.03e-05	1.66e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—type 1 diabetes mellitus	9.23e-06	1.48e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—type 1 diabetes mellitus	8.93e-06	1.43e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—type 1 diabetes mellitus	8.93e-06	1.43e-05	CbGpPWpGaD
